4.10 Delayed Data As of Apr 25 | ![]() Today’s Change | 3.20 Today|||52-Week Range 9.41 | -40.56% Year-to-Date |
Previous close | 4.10 |
Today’s open | 3.95 |
Day’s range | 3.95 - 4.15 |
Volume | 58 |
Average volume (3 months) | 15,216 |
Market cap | $56.3M |
Earnings growth (last year) | -- |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | +40.00% |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 0.60 |
Today’s change | Today’s % change | |
---|---|---|
CHMAChiasma Inc | 0.00 | 0.00% |
XENEXenon Pharmaceutical... | 0.00 | 0.00% |
APDNApplied DNA Sciences... | -0.01 | -0.37% |
EGLTEgalet Corp | +0.01 | +0.98% |
Next reporting date | May 10, 2018 |
EPS forecast (this quarter) | -$0.56 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$21.3M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Natasha Giordano |
Chief Financial Officer Rita M. O'Connor |
Corporate headquarters Houston, Texas |